Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo.

Organisations Organisation Veloxis Pharmaceuticals A/S (Nasdaq OMX Copenhagen: VELO)
  Today LifeCycle Pharma A/S
  Organisation 2 Asahi Kasei Pharma Denmark A/S
  Group Asahi Kasei (Group)
Products Product MeltDose® drug delivery technology
  Product 2 Envarsus XR
Index term Index term Veloxis Pharmaceuticals–Asahi Kasei: investment, 201911– recommended cash offer DKK 8.9b ($1.3b) by Asahi Kasei Pharma Denmark A/S
Persons Person Collard, Craig (Veloxis Pharmaceuticals 201911 CEO)
  Person 2 Kobori, Hideki (Asahi Kasei 201709 President + Representative Director of Asahi Kasei Corp)
     


   
Record changed: 2019-11-27

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for Veloxis Pharmaceuticals A/S (Nasdaq OMX Copenhagen: VELO)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top